{"result": {"id": "chatcmpl-167", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "Antiangiogenic therapy is a treatment modality used to reduce fibrosis in patients with myelofibrosis (MNV3). It works by blocking the growth of new blood vessels, which can help to limit the spread of fibrosis and improve patient outcomes.  It is also a type of cancer treatment. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743185908, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 61, "prompt_tokens": 205, "total_tokens": 266, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"ANTIANGIOGENIC THERAPY\"\nDescription List: [\"**Antiangiogenic therapy** is a treatment modality used to reduce fibrosis in patients with Myelofibrosis (MNV3). It works by blocking the growth of new blood vessels, which can help to limit the spread of fibrosis and improve patient outcomes. \\n\", \"A type of cancer treatment\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_43833915d78b930eee584fc92b70618c73867356e106e11959e1f8e99436ffa4_v2"}